Biotech Values

[jbog]

jmkobers,

Mnta but the stock price continues to defy reason.

Does it?

Without seeing some of the "real" facts regarding the financials, without knowing the future FDA actions and without knowing what future possible dilution might be coming, it makes Momenta very hard to price for the next year.

So in short how can you value a company if you can't accurately estimate their income, you then find out they have 'off balance sheet' liabilities and lastly it gets involved in lawsuits which put everything at risk?

In the long run, I think everything will be fine but it'll take time to work everything out.

I thought I was smart selling in $22's and re-buying in the $18's but I might have been too early in re-buying.

We'll see